NiKang Therapeutics

NiKang Therapeutics is a clinical-stage biotechnology company headquartered at 200 Powder Mill Road, Building E500, Wilmington, Delaware, founded in 2017 to discover and develop innovative small molecule medicines that help patients fight cancer. The company works from deep insights into disease biology and molecular pathways and applies structure-based drug design to targets long considered difficult to drug, spanning both inhibitor and targeted-protein-degradation modalities. Its lead programme, NKT2152, is an orally bioavailable allosteric HIF2alpha inhibitor in Phase 1/2 for clear cell renal cell carcinoma, VHL disease and other solid tumours; NKT3964 is a first-in-class selective CDK2 degrader in Phase 1 for advanced or metastatic solid tumours; NKT5097 is a first-in-class dual CDK2/4 degrader, also in Phase 1; and a KRAS G12D small molecule programme sits in discovery and IND-enabling work. NiKang raised a $10 million Series A in December 2017, a $50 million Series B in September 2020 and a $200 million Series C in May 2021, and has partnered its chemistry with Erasca on SHP2 and with Pfizer, Hansoh and Roche on HIF2. NiKang Therapeutics runs no developer program and publishes no product API, developer portal, API reference or machine-readable specification of its own. The only machine-readable surface reachable without credentials is the WordPress REST content API behind www.nikangtx.com, which is catalogued here — 210 registered routes across 17 namespaces, of which the anonymously readable read-only content families are described in openapi/.

NiKang Therapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Precision Medicine.

NiKang Therapeutics’ developer surface includes product news, authentication, and 23 more developer resources.

🌐 Visit website 📡 Source on GitHub

17.2/100 emerging ▬ flat Agent 7/100 agent aware Front door AI 1/6 silent saas Full breakdown ↓
scored 2026-10-09 · rubric v0.23.0

AccessOpen

1 API

Company Biotechnology Pharmaceuticals Oncology Precision Medicine Drug Discovery Targeted Protein Degradation Clinical Trials Life Sciences content-api

Kin Score

Kin Score How this is scored →
scored 2026-10-09 · rubric v0.23.0

Composite quality — 17.2/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 3.9 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 5.5 / 9

Regulatory Posture 3.6 / 15

Agent readiness — 7/100 · agent aware

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 10 / 10

Idempotency 0 / 9

Stable Error Semantics 8 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 7 / 7

Typed Event Surface 0 / 6

Agent Skills 5 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/nikang-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

APIs 1

Individual APIs this provider publishes, each with its own machine-readable definition.

NiKang Therapeutics Website (WordPress REST)

The public WordPress REST API (wp-json) of the NiKang Therapeutics website at www.nikangtx.com: the route index of the site's content management system, catalogued as one site s...

Pricing Plans 1

Published pricing tiers and plan structures.

Nikang Therapeutics Plans Pricing

0 plans

PLANS

Rate Limits 1

Documented rate limits and quota policies.

Nikang Therapeutics Rate Limits

0 limits

RATE LIMITS

OpenAPI Overlays 1

Overlays applied on top of this provider's contracts. Each card says who wrote it: a document the provider publishes, or one API Evangelist derived or generated.

Nikang Therapeutics Content Overlay

10 actions · update · openapi

GENERATED

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Nikang Therapeutics Authentication

0 schemes

SECURITY

Nikang Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

X-MCPServerCandidate

X-MCPServerCandidate

LLMsTxt

LLMsTxt

AgentSkill

AgentSkill

Design & Contract 5

Pagination, idempotency, versioning, errors, and events

Conventions

Conformance

ErrorCatalog

Lifecycle

DataModel

Build 1

SDKs, sample code, and the tooling you integrate with

Packages

Packages

Access & Security 2

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Authentication

Authentication

Operate 1

Status, limits, changes, and where to get help

RateLimits

RateLimits

Commercial 3

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Plans

Plans

Company 7

The organization behind the API

Website

About

News

BlogRSS

Careers

Jobs

LinkedIn

Scroll for all 7

Other 3

Properties that don't map to a standard resource type

Pipeline

Pipeline

SecondaryMarket

SecondaryMarket

Overlay

Overlay

Source (apis.yml)

aid: nikang-therapeutics
name: NiKang Therapeutics
description: NiKang Therapeutics is a clinical-stage biotechnology company headquartered at 200 Powder Mill Road, Building
  E500, Wilmington, Delaware, founded in 2017 to discover and develop innovative small molecule medicines that help patients
  fight cancer. The company works from deep insights into disease biology and molecular pathways and applies structure-based
  drug design to targets long considered difficult to drug, spanning both inhibitor and targeted-protein-degradation modalities.
  Its lead programme, NKT2152, is an orally bioavailable allosteric HIF2alpha inhibitor in Phase 1/2 for clear cell renal
  cell carcinoma, VHL disease and other solid tumours; NKT3964 is a first-in-class selective CDK2 degrader in Phase 1 for
  advanced or metastatic solid tumours; NKT5097 is a first-in-class dual CDK2/4 degrader, also in Phase 1; and a KRAS G12D
  small molecule programme sits in discovery and IND-enabling work. NiKang raised a $10 million Series A in December 2017,
  a $50 million Series B in September 2020 and a $200 million Series C in May 2021, and has partnered its chemistry with Erasca
  on SHP2 and with Pfizer, Hansoh and Roche on HIF2. NiKang Therapeutics runs no developer program and publishes no product
  API, developer portal, API reference or machine-readable specification of its own. The only machine-readable surface reachable
  without credentials is the WordPress REST content API behind www.nikangtx.com, which is catalogued here — 210 registered
  routes across 17 namespaces, of which the anonymously readable read-only content families are described in openapi/.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: true
  label: Hosted service · you call their endpoint
  confidence: high
  source:
  - openapi
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: open
  trial: false
  try_now: false
  public: true
  label: Open access
  confidence: medium
  source:
  - authentication
  - rate-limits
  - security
  generated: '2026-09-02'
  method: derived
image: https://www.nikangtx.com/wp-content/uploads/2023/10/nikang-logo-footer.png
url: https://raw.githubusercontent.com/api-evangelist/nikang-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Drug Discovery
- Targeted Protein Degradation
- Clinical Trials
- Life Sciences
- content-api
tags_raw:
- Company
- biotechnology
- pharmaceuticals
- oncology
- precision-medicine
- drug-discovery
- targeted-protein-degradation
- clinical-trials
- life-sciences
- content-api
apis:
- aid: nikang-therapeutics:nikangtx-com-website-wordpress-rest
  name: NiKang Therapeutics Website (WordPress REST)
  description: 'The public WordPress REST API (wp-json) of the NiKang Therapeutics website at www.nikangtx.com: the route
    index of the site''s content management system, catalogued as one site surface rather than as separate APIs.'
  baseURL: https://www.nikangtx.com/wp-json
  tags:
  - WordPress
  x-surface: platform-generated
  properties:
  - type: Documentation
    url: https://www.nikangtx.com/wp-json
  x-platform: wordpress
  x-platform-surface: rest
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/nikang-therapeutics-domain-security.yml
- type: Website
  url: https://www.nikangtx.com/
- type: About
  url: https://www.nikangtx.com/about-us/
- type: Pipeline
  url: https://www.nikangtx.com/science-and-pipeline/
- type: News
  url: https://www.nikangtx.com/news/
- type: BlogRSS
  url: https://www.nikangtx.com/feed/
- type: Careers
  url: https://www.nikangtx.com/careers/
- type: Jobs
  url: https://www.nikangtx.com/jobs/
- type: PrivacyPolicy
  url: https://www.nikangtx.com/privacy-policy-statement/
- type: TermsOfService
  url: https://www.nikangtx.com/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/nikang-therapeutics-inc
- type: SecondaryMarket
  url: https://forgeglobal.com/nikang-therapeutics_stock/
- type: Overlay
  url: overlays/nikang-therapeutics-content-overlay.yaml
- type: Authentication
  url: authentication/nikang-therapeutics-authentication.yml
- type: Conventions
  url: conventions/nikang-therapeutics-conventions.yml
- type: Conformance
  url: conformance/nikang-therapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/nikang-therapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/nikang-therapeutics-lifecycle.yml
- type: DataModel
  url: data-model/nikang-therapeutics-data-model.yml
- type: RateLimits
  url: rate-limits/nikang-therapeutics-rate-limits.yml
- type: Plans
  url: plans/nikang-therapeutics-plans-pricing.yml
- type: Packages
  url: packages/nikang-therapeutics-packages.yml
- type: X-MCPServerCandidate
  url: mcp/nikang-therapeutics-mcp.yml
  note: 'Renamed from MCPServer 2026-09-03 (roadmap#247): the manifest self-describes as status: candidate — a tool list derived
    from the published API contracts, not an existing server. The scorer already read the manifest and reported mcp_server
    correctly; the MCPServer type was crediting the artifact-type surfaces with a server that does not exist.'
- type: LLMsTxt
  url: llms/nikang-therapeutics-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-26'
  status: enriched
  artifacts_added: 27
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/nikang-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/nikang-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/nikang-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.